10177-ML-5 HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANT FOR RECURRENT CNS LYMPHOMA
Kazuhiko Mishima, Naoki Tkahashi, Tomonari Suzuki, Reina Mizuno, Mitsuaki Shirahata · 2023
Read 10177-ML-5 HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANT FOR RECURRENT CNS LYMPHOMA by Kazuhiko Mishima, Naoki Tkahashi, Tomonari Suzuki, Reina Mizuno, Mitsuaki Shirahata (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10710572.txt.
Description
Kazuhiko Mishima and co-authors report results for high-dose chemotherapy with a patient's own stem cells, used when brain lymphoma returns. Returned disease of this kind has a poor outlook and no standard cure. Their 2023 study covers nine patients treated at one Japanese university hospital since twenty twenty-one.
After a first drug round shrank the disease, stem cells were gathered from the blood. Strong conditioning drugs followed, then the cells were returned. All patients had low blood counts and most had fever episodes, but all recovered and none died from treatment. Eight of the nine were alive without recurrence at report time. The authors call the approach an effective salvage option for this hard group.
Catalog record
| CREATOR | Kazuhiko Mishima, Naoki Tkahashi, Tomonari Suzuki, Reina Mizuno, Mitsuaki Shirahata |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |